Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Train-of-four monitoring vs clinical assessment for continuous neuromuscular blockade in pediatric ICU
TCTR20240328002Phase 2Recruiting
- Sponsor
- Dr. Suvikrom Law
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial in critical illness (2 arms), sponsored by Dr. Suvikrom Law. Primary endpoint: Continuous neuromuscular blockade dose. Started Apr 2024; status: recruiting.
02
Conditions
critical illness
Beyond the preview
Go deeper on TCTR20240328002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240328002.